Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Alphabet Inc. Class C's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.15T | |
|---|---|---|
| Revenue (ttm) | 445.9B | |
| Net income (ttm) | 244.1B | |
| EPS (ttm) | $19.9 | |
| Shares out | 12.2B | |
| P/E (trailing) | 16.1x | |
| P/E (forward) | 22.1x | |
| Dividend | $0.88 (0.27%) | |
| Volume | 17,944,160 | |
| Beta | 1.21 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $257.64B | $282.84B | $307.39B | $350.02B | $402.84B | +11.8% |
| Gross profit | $146.70B | $156.63B | $174.06B | $203.71B | $240.30B | +13.1% |
| Operating income | $78.71B | $74.84B | $84.29B | $112.39B | $129.04B | +13.2% |
| Net income | $76.03B | $59.97B | $73.80B | $100.12B | $132.17B | +14.8% |
| EPS (diluted) | $5.61 | $4.56 | $5.80 | $8.04 | $10.81 | +17.8% |
| EBITDA | $103.52B | $85.16B | $97.97B | $135.39B | $180.70B | +14.9% |
| R&D | $31.56B | $39.50B | $45.43B | $49.33B | $61.09B | +17.9% |
| SG&A | $13.51B | $15.72B | $16.43B | $14.19B | $21.48B | +12.3% |
Recent company headlines from major financial publishers.
If revenue meets expectations, profit and cash must still follow before the enlarged build creates enough value to change the valuation view.
This case strengthens if FY2027 revenue meets expectations and free cash flow improves despite the spending build. It weakens if higher spending keeps absorbing operating cash.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.9% | $343 | $356 | $371 | $390 | $414 |
| 8.9% | $308 | $317 | $327 | $338 | $353 |
| 9.9% | $282 | $288 | $295 | $303 | $312 |
| 10.9% | $261 | $266 | $270 | $276 | $282 |
| 11.9% | $244 | $248 | $251 | $255 | $259 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |